GABA/glutamate. Even though large-scale Copy Number Variation (CNV) studies in schizophrenia, autism, and intellectual disability were en vogue only a few years ago, it became quiet around these type of studies more recently. Now, a recent study in Neuron revisits CNV analysis in schizophrenia with the largest sample size to date, cancelling out much of the noise that smaller studies had to fight with. Find out how the authors managed to demonstrate a contribution of the GABAergic and glutamatergic system to schizophrenia by sheer numbers. Continue reading →